Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of "Ready-to-Use" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19

NCT04477083 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT04477083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04477083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of "Ready-to-Use" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19
Lead sponsor
Mansoura University
Phase
Not applicable
Overall status
Unknown status
Start date
July 15, 2020
Completion date
August 15, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, hydroxychloroquine adverse reaction